Most studies report reduced reelin levels in major depression, autism, and bipolar disorder (at the tissue and plasma levels), but not schizophrenia, which is associated with an increase in plasma reelin levels at baseline and during the first episode [38,39], or in the brain tissue of patients with Alzheimer’s disease [40]. Here, RELN is linked to early-onset autosomal dominant Alzheimer disease.